SCOTT FREEMAN: Open Payments
NPI 1508802752 · PALM HARBOR, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$45,841 in 233 payments from 24 companies in 2025. Trend: 2023 $33,907 · 2024 $45,123 · 2025 $45,841
Speaker / faculty: $33,726Food & beverage: $6,844Consulting: $2,800Travel & lodging: $2,464Education: $7
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 60 | $17,052 |
| Amgen Inc. | 35 | $14,892 |
| Regeneron Healthcare Solutions, Inc. | 28 | $5,833 |
| GENZYME CORPORATION | 9 | $3,451 |
| Janssen Biotech, Inc. | 8 | $1,246 |
| E.R. Squibb & Sons, L.L.C. | 3 | $783 |
| ABBVIE INC. | 21 | $633 |
| Botanix SB Inc | 9 | $377 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $260 |
| Galderma Laboratories, L.P. | 6 | $203 |
Products named: Bimzelx, DUPIXENT, Otezla, TREMFYA, SOFDRA, RINVOQ, SKYRIZI, SPEVIGO.
Industry payments across FL — which companies pay providers there.
